Valvular Disease

ACCP Valvular Disease

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/76044

Contents of this Issue

Navigation

Page 4 of 7

Figure 1. Prosthetic Valves Mechanical Mitral Aortic Bioprosthetic NSR Mitral or prophy dose UFH Full or prophy dose LMWH Bridging (range 2.0-3.0) VKA – target INR 2.5 VKA – target INR 3.0 (range 2.5-3.5) Consider adding antiplatelet Rx Endocarditis Infective Suspend VKA pending invasive procedures Fibrinolysis Surgery Right PVT Left × 3 mo × 3 mo Aspirin 50-100 mg/d + clopidogrel (75 mg/d) After 3 mo Aspirin 50-100 mg/d Antiplatelet Rx Aortic Transcatheter NSR Valve Repair Aortic Mitral NSR Thrombus < 0.8 cm2 Thrombus ≥ 0.8 cm2

Articles in this issue

Archives of this issue

view archives of Valvular Disease - ACCP Valvular Disease